Patient-controlled epidural analgesia or multimodal pain regimen with periarticular injection after total hip arthroplasty: a randomized, double-blind, placebo-controlled study

この研究はハイインパクトの可能性があります。 OEのAI駆動型ハイインパクト指標は、論文が掲載されたジャーナルと論文自体の科学的内容の両方からのシグナルを統合することで、論文が持つ可能性の高い影響力を推定します。 最先端の自然言語処理を用いて開発されたOEハイインパクトモデルは、ジャーナルのインパクトファクターのみよりも、研究の将来の引用実績をより正確に予測します。 これにより、臨床的に意義のある研究をより早く認識することが可能になり、読者は将来の診療を形成する可能性が最も高い論文に集中することができます。

90 patients scheduled for total hip arthroplasty were randomized to receive either a periarticular injection at the end of the procedure and sustained-release oxycodone (10mg) for postoperative analgesia, or patient-controlled epidural analgesia with bupivacaine and hydromorphone. The primary outcome was time to discharge readiness. Additional outcomes included numeric rating scale (NRS) for pain, opioid consumption, opioid-related symtoms on the Opioid-Related Symptom Distress Scale (ORSDS), patient satisfaction and the Quality of Recovery (QoR)-40 patient survey. Results demonstrated no significant differences in time to discharge readiness between groups. Over the first 3 postoperative days, overall pain over time during walking and physical therapy was higher with periarticular injection, as well oral opioid consumption. In the same time frame, opioid-related symptoms were higher with patient-controlled epidural analgesia. Patient satisfaction and quality of recovery were rated similarly between groups.